RICHARD ERIC DAVIS to Cell Proliferation
This is a "connection" page, showing publications RICHARD ERIC DAVIS has written about Cell Proliferation.
Connection Strength
0.106
-
The p44/wdr77-dependent cellular proliferation process during lung development is reactivated in lung cancer. Oncogene. 2013 Apr 11; 32(15):1888-900.
Score: 0.043
-
PSGL-1/selectin and ICAM-1/CD18 interactions are involved in macrophage-induced drug resistance in myeloma. Leukemia. 2013 Mar; 27(3):702-10.
Score: 0.011
-
Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myeloma. Blood. 2012 Oct 18; 120(16):3260-70.
Score: 0.011
-
The pan-deacetylase inhibitor panobinostat induces cell death and synergizes with everolimus in Hodgkin lymphoma cell lines. Blood. 2012 Apr 26; 119(17):4017-25.
Score: 0.011
-
Casein kinase 1alpha governs antigen-receptor-induced NF-kappaB activation and human lymphoma cell survival. Nature. 2009 Mar 05; 458(7234):92-6.
Score: 0.009
-
Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphoma. Blood. 2008 Apr 01; 111(7):3701-13.
Score: 0.008
-
A loss-of-function RNA interference screen for molecular targets in cancer. Nature. 2006 May 04; 441(7089):106-10.
Score: 0.007
-
Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling. Clin Cancer Res. 2005 Jan 01; 11(1):28-40.
Score: 0.006